January 17, 2018 by Chain Drug Review
2018 Retail Forecast, Albertsons, Alex Gourlay, AmerisourceBergen, Brian Nightengale, Cardinal Health, Care Pharmacies, Carmen Churcott, Chris Dimos, CVS Health, Discount Drug Mart, Fruth Pharmacy, Genoa, Good Neighbor Pharmacy, Hy-Vee, Jeff Leger, John Figueroa, John Standley, Kristin Williams, Larry Merlo, Lynne Fruth, Mark Panzer, McKesson, Medicine Shoppe, Michael Wysong, Mike Eby, Pharmaca, Pharmasave, Richard Willis, Rite Aid, Robert Mauch, Shoppers Drug Mart, Steve Lawrence, Todd Treon, Walgreens Boots Alliance
Featured Articles, Leading Headlines, Pharmacy, Retail News

What will the second year of the Trump administration look like? Is the demise of the Affordable Care Act imminent? Will pharmacists get the greater role in health care they have long sought? These are among the questions top chain drug industry executives are pondering as they look to 2018. With spiraling health care costs and
April 24, 2017 by Brian Bossetta
Care Pharmacies, Michael Wysong
Business, Leading Headlines, Retail News

LINTHICUM, Md. — The unique operating model of Care Pharmacies Cooperative has been the key to the company’s record growth, says chief executive officer Michael Wysong. The company’s unique operating structure, he says, allows its members to take full advantage of the logistical and operational efficiencies of the chain while maintaining their uniqueness as independent
February 8, 2016 by Brian Bossetta and Chain Drug Review
Care Pharmacies, Mark Ey, Michael Wysong
2016, Issue 02-08-2016, Issues, News
LINTHICUM, Md. — Care Pharmacies has promoted Mark Ey to vice president of pharmacy operations. He will lead all chain-level operational functions. “We are very excited to have Mark take on an increased level of responsibility within the drug chain,”stated Michael Wysong, chief executive officer. “Mark’s direct impact on our ability to serve our customers
January 19, 2016 by Chain Drug Review
Care Pharmacies, Mark Ey, Michael Wysong
Leading Headlines, Pharmacy, Retail News

LINTHICUM, Md. — Care Pharmacies Cooperative Inc. has promoted Mark Ey to vice president of pharmacy operations. The pharmacy co-op said Monday that with the promotion, Ey will oversee all chain-level operational functions. He previously held the title of director of operations and support services. A University of Maryland School of Pharmacy graduate, Ey also
January 18, 2016 by John Schultz and Chain Drug Review
Care Connect, Care Pharmacies Cooperative, Michael Wysong, specialty pharmacy
2016, Issue 01-18-2016, Issues, News
LINTHICUM, Md. — Care Pharmacies Cooperative Inc. has launched Care Connect, a specialty pharmacy internal network designed for its member pharmacies and other retail independent pharmacies. “Care Connect was designed to provide the highest level of care to our specialty patients,” stated chief executive officer Michael Wysong. Care Connect is a comprehensive care management model
January 5, 2016 by Chain Drug Review
Aureus Health Services, Care Connect, Care Pharmacies, Michael Wysong, specialty drugs, specialty pharmacy
Leading Headlines, Pharmacy, Retail News

LINTHICUM, Md. — Care Pharmacies Cooperative Inc. has officially launched its proprietary specialty pharmacy network, called Care Connect. The network will serve the cooperative’s member pharmacies as well as independent retail pharmacies. Care unveiled plans for the network last May in announcing its partnership with specialty pharmacy provider Aureus Health Services Inc. Under Care Connect,
September 25, 2015 by Chain Drug Review
Ateb, Care Pharmacies Cooperative, Michael Cantrell, Michael Wysong, retail pharmacy industry
Business, Leading Headlines, Retail News

LINTHICUM, Md. — Retail pharmacy industry veteran Michael Cantrell has joined the board of directors at Care Pharmacies Cooperative Inc. Care Pharmacies said Cantrell, vice president of pharmacy network development at Ateb Inc., will serve a three-year term. Cantrell has more than 30 years of industry experience. Before joining Ateb in July, he served as
September 14, 2015 by John Schultz and Chain Drug Review
Care Pharmacies, Michael Wysong, Molly Carr
2015, Issue 09-14-2015, Issues, News
LINTHICUM, Md. — Care Pharmacies has extended chief executive officer Michael Wysong’s employment contract for an undisclosed period. During Wysong’s tenure, Care Pharmacies’ sales have increased by more than 300%, and the company has gained recognition by the National Retail Federation. “Care Pharmacies is delighted to have Wysong continue in his current leadership role,” Care
August 31, 2015 by Chain Drug Review
Care Pharmacies Cooperative, Michael Wysong, Molly Carr
Business, Leading Headlines, Retail News

LINTHICUM, Md. — Care Pharmacies Cooperative Inc. has extended the contract of chief executive officer Michael Wysong. The pharmacy co-op said that during Wysong’s leadership, the organization has seen record growth, with sales surging more than 300% and the company being recognized as a “Hot 100” retailer in three out of the last four years
May 14, 2015 by Chain Drug Review and Chain Drug Review
Aureus Health Services, Care Pharmacies Cooperative, Care Pharmacies Specialty Network, Michael Nameth, Michael Wysong, specialty drugs, specialty pharmacy
Leading Headlines, Pharmacy, Retail News

LINTHICUM, Md., and PITTSBURGH — Care Pharmacies Cooperative Inc. has partnered with Aureus Health Services Inc. to launch the Care Pharmacies Specialty Network. The companies said Thursday that under the partnership, Aureus will provide specialty pharmacy management services to Care’s member pharmacies, as well as resources to support the needs of their specialty patients and providers. Care Pharmacies has retail and
May 5, 2015 by Greg Jacobson and Chain Drug Review
Care Pharmacies, Mark Ey, Michael Wysong
Featured Articles, Leading Headlines, Retail News

LINTHICUM, Md. — For Care Pharmacies, 2014 was a year of impressive top-line growth while the company continued to focus on infrastructure improvement with a number of technology initiatives. Sales for the year soared 26.6% to $463.3 million, driven largely by the entry into the market of hepatitis C drugs, says chief executive officer Michael